PT PRAMITA - INDONESIA cq. PRAMITA Clinical Laboratory as the best health service provider in diagnostic quality and complete services under one roof has more than 35 branches in Indonesia, on 15 - 17 March 2023 was selected to attend the Singapore - Indonesia Leader's Retreat held in Singapore.

During the Indonesia-Singapore business meeting, an MOU was signed between Mesh Bio Singapore (represented by Dr. Andrew Wu, Co-Founder & CEO of Mesh Bio) and PT. PRAMITA cq. Lab. PRAMITA Indonesia Clinic (represented by Dr. Nabil Fachliansyah - Vice President Director of PT. PRAMITA) witnessed by Mr. Dr(HC) Ir. Airlangga Hartarto, MBA -Coordinating Minister for the Economy of the Republic of Indonesia.

The collaboration in question is the application of MeshBio - DARA Health Intelligence Platform software, consisting of: new analysis technology, combining metabolic disease digital twins, scientific data and predictive analysis to produce preventive actions.
As an updated innovation for the first time in early 2023 HEALTH ANALYSIS was launched by the Lab. PRAMITA Clinic.

With Health Analysis, patients will get health examination results based on precise predictive analysis at an affordable cost.